Zelira Therapeutics マネジメント
マネジメント 基準チェック /34
Zelira Therapeutics' CEO is Oludare Odumosu, appointed in Jan 2021, has a tenure of 3.83 years. total yearly compensation is A$557.33K, comprised of 81% salary and 19% bonuses, including company stock and options. directly owns 1.16% of the company’s shares, worth A$93.55K. The average tenure of the management team and the board of directors is 4.9 years and 4.9 years respectively.
主要情報
Oludare Odumosu
最高経営責任者
AU$557.3k
報酬総額
| CEO給与比率 | 81.0% |
| CEO在任期間 | 3.8yrs |
| CEOの所有権 | 1.2% |
| 経営陣の平均在職期間 | 4.9yrs |
| 取締役会の平均在任期間 | 4.9yrs |
経営陣の近況
Recent updates
Zelira Therapeutics Limited's (ASX:ZLD) CEO Will Probably Find It Hard To See A Huge Raise This Year
Nov 08
Is Zelira Therapeutics (ASX:ZLD) In A Good Position To Invest In Growth?
Jul 14Here's Why Zelira Therapeutics (ASX:ZLD) Must Use Its Cash Wisely
Jan 19Will Zelira Therapeutics (ASX:ZLD) Spend Its Cash Wisely?
Sep 25Will Zelira Therapeutics (ASX:ZLD) Spend Its Cash Wisely?
Jun 03A Quick Analysis On Zelira Therapeutics' (ASX:ZLD) CEO Compensation
Dec 31
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | AU$557k | AU$451k | -AU$37m |
| Mar 31 2024 | n/a | n/a | -AU$36m |
| Dec 31 2023 | n/a | n/a | -AU$36m |
| Sep 30 2023 | n/a | n/a | -AU$21m |
| Jun 30 2023 | AU$479k | AU$445k | -AU$6m |
| Mar 31 2023 | n/a | n/a | -AU$8m |
| Dec 31 2022 | n/a | n/a | -AU$10m |
| Sep 30 2022 | n/a | n/a | -AU$11m |
| Jun 30 2022 | AU$642k | AU$449k | -AU$12m |
| Mar 31 2022 | n/a | n/a | -AU$11m |
| Dec 31 2021 | n/a | n/a | -AU$10m |
| Sep 30 2021 | n/a | n/a | -AU$9m |
| Jun 30 2021 | AU$560k | AU$318k | -AU$9m |
| Mar 31 2021 | n/a | n/a | -AU$8m |
| Dec 31 2020 | n/a | n/a | -AU$8m |
| Sep 30 2020 | n/a | n/a | -AU$8m |
| Jun 30 2020 | AU$321k | AU$114k | -AU$7m |
報酬と市場: Oludare's total compensation ($USD368.09K) is about average for companies of similar size in the Australian market ($USD299.27K).
報酬と収益: Oludare's compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
Oludare Odumosu
3.8yrs
在職期間
AU$557,327
報酬
Dr. Oludare Odumosu serves as Director of Zelira Therapeutics Limited (formerly Zelda Therapeutics Ltd) since December 02, 2019. He serves as the Managing Director & Global Chief Executive Officer of Zelir...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder & Chairman | 4.9yrs | AU$151.31k | 3.78% A$ 304.5k | |
| MD, Global CEO & Director | 3.8yrs | AU$557.33k | 1.16% A$ 93.6k | |
| Executive Director | no data | AU$323.02k | データなし | |
| Company Secretary & Non-Executive Director | 8.1yrs | AU$65.18k | 0.069% A$ 5.6k | |
| Vice President of Finance & Accounting | no data | データなし | データなし | |
| Clinical Trial Consultant | no data | データなし | データなし |
4.9yrs
平均在職期間
経験豊富な経営陣: ZLD's management team is considered experienced (4.9 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder & Chairman | 4.9yrs | AU$151.31k | 3.78% A$ 304.5k | |
| MD, Global CEO & Director | 4.9yrs | AU$557.33k | 1.16% A$ 93.6k | |
| Executive Director | 1.8yrs | AU$323.02k | データなし | |
| Company Secretary & Non-Executive Director | 2.8yrs | AU$65.18k | 0.069% A$ 5.6k | |
| Member of Medical Advisory Board | no data | AU$12.00k | 2.22% A$ 179.1k | |
| Member of Medical Advisory Board | no data | データなし | データなし | |
| Member of Medical Advisory Board | no data | データなし | データなし | |
| Member of Medical Advisory Board | 8.8yrs | データなし | データなし | |
| Member of Medical Advisory Board | 8.7yrs | データなし | データなし | |
| Scientific & Medical Advisory Board | 6.3yrs | データなし | データなし | |
| Scientific & Medical Advisory Board | 6.3yrs | データなし | データなし | |
| Independent Non-Executive Director | 1.4yrs | AU$105.76k | データなし |
4.9yrs
平均在職期間
経験豊富なボード: ZLD's board of directors are considered experienced (4.9 years average tenure).